By Amy Johnson – For pharmaceutical manufacturers and life sciences organizations, ensuring patients use medications as intended is central to outcomes, safety, and adherence. But when EHR prescribing workflows introduce ambiguity, especially with patient instructions, those goals become harder to achieve.
Read More
By Amber Glende – If you work in life sciences, whether in pharma, diagnostics, or vaccines, Federally Qualified Health Centers might not be on your radar. Many manufacturers focus their commercial strategies on large health systems, private practices, and specialty networks, leaving FQHCs largely untapped.
By Kim Boyd – In an era where data fluidity is transforming healthcare, life sciences manufacturers must stay attuned to evolving Health IT policies given that many of these policies have downstream effects on life sciences and access to expanded deidentified and aggregated datasets.
By Krishna Subramanian – The digitization of healthcare driven by the explosive growth of medical devices and point-of-care software in recent years has been a game changer. Consider the speed at which effective COVID-19 vaccines were developed saving millions of lives and allowing the global economy to recover faster.